Predictors of sorafenib benefit in patients with hepatocellular carcinoma

Jackson, Richard, Psarelli, Eftychia ORCID: 0000-0002-3102-0288, Berhane, Sarah and Johnson, Philip J ORCID: 0000-0003-1404-0209 (2018) Predictors of sorafenib benefit in patients with hepatocellular carcinoma. Journal of Hepatology, 68 (3). pp. 619-620.

Text Predictors of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.docx - Author Accepted Manuscript Download (25kB)

Item Type:	Article
Uncontrolled Keywords:	Humans, Carcinoma, Hepatocellular, Liver Neoplasms, Phenylurea Compounds, Niacinamide, Prognosis, Sorafenib
Depositing User:	Symplectic Admin
Date Deposited:	15 Jan 2018 14:54
Last Modified:	19 Jan 2023 06:44
DOI:	10.1016/j.jhep.2017.09.028
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3016140